🔗 Share this article

An underground market for unapproved weight-loss medications is propelled by TikTok fitness influencers and vendors on messaging platforms, according to new investigations.

Experimental Drug Gaining Traction Via Social Media

The experimental drug, which remains in research studies, is being promoted by social media influencers for its alleged fat-burning properties. Followers are encouraged to message these accounts privately for source information, while also obtaining discount codes.

Active Trade on Social Networks

Additionally, a flourishing market exists on Telegram, where groups with thousands of participants share “before and after” photos, injection guides and claims of rapid British shipping. Vendors promote the substance there before redirecting buyers to other platforms for transactions.

Understanding The Experimental Drug

Retatrutide is an investigational injection developed by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could help individuals reduce up to 25% of their total weight. Referred to as the “triple G”, the drug is being promoted online as the successor to Ozempic.

Healthcare Professionals Voice Concerns

Nevertheless, physicians and pharmacists have cautions that the distribution of what remains an unapproved medication in the UK is worrisome and could result in users injecting substances of uncertain source.

Several experts said the demand for retatrutide could be connected to the rising price of licensed weight loss treatments such as Mounjaro.

Legal Status and Implementation

Selling the unapproved drug on social media or Telegram is prohibited in the UK, as it is an unlicensed drug that must not be promoted or distributed for human use under the British medical regulations.

Several influencers attempt to circumvent the regulations by calling to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and supply can still violate medicines, marketing, and consumer laws, risking fines, prosecution or prison.

Platform Response and Material Elimination

Based on the social media company, the platform has taken down violative material and prohibited related hashtags and query recommendations. The organization said it was dedicated to keeping the platform secure and allocating resources in enhancing enforcement strategies.

Online Marketplace Operations

Research also found communities with up to nine thousand participants marketing the experimental drug using Telegram's integrated search feature, which functions like a public directory. Entering “retatrutide” immediately brings up groups with numerous of users, populated with images of slimming results, positive reviews and detailed instructions for preparing or injecting at home.

After moments of joining one group, a vendor posted WhatsApp details, where most purchases take place. The seller provided an instruction manual and guaranteed shipping within two days. When questioned whether the product was genuine, one vendor said: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. Not one asked about weight, medical conditions or past usage.

Item Information and Pricing

Within these groups, posts show dark colored parcels with postal service labels, stating to include new batches. One communication read: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, prepared at residence with sterile water, or pre-filled injectors usually priced at £160 for 20mg. When questioned how long a injector should be used, vendors give conflicting responses ranging from a several days to “depends on your body”.

Platform Oversight and Safety Actions

A representative for the messaging service stated it regularly moderated harmful content on its service including content that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“Individuals are administering materials they can’t verify. Although the research behind this drug is sound, these digital versions may not contain what they advertise,” said Jason Murphy, the head of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of an online medical service connected the increase in demand to current price rises for approved slimming drugs such as Mounjaro. “With costs rising, individuals are using online platforms. But counterfeit treatments are extremely risky. You can’t be certain what’s inside or whether the conditions they were produced in was clean,” she said.

Her team has previously seen patients injured by personal administration from unverified suppliers. “We recognize the disappointment, but purchasing from Telegram or WhatsApp is taking chances with your health,” stated the doctor. “These materials could be contaminated or improperly measured.”

Producer Statement

A spokesperson from the pharmaceutical company said the substance was in phase 3 research studies and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Consequently at this point no one can sell [it] for human use,” they said, adding that any item “falsely representing itself as a Lilly experimental product not yet approved … may expose users to potentially serious health risks”.